In May 2013, DePuy announced its decision to discontinue sales of its ULTAMET® Metal-on-Metal Articulation worldwide.
This decision was based on low demand for ULTAMET Metal-on-Metal, the availability of alternative options that meet the clinical needs of patients and a proposed change in FDA regulation of all metal-on-metal total hip replacements, including ULTAMET Metal-on-Metal.
The discontinuation was announced in conjunction with DePuy’s ongoing efforts to simplify and streamline the company’s product portfolio by focusing on fewer, worldwide strategic product platforms to meet patient and clinician needs and ensure long-term growth.
At the time of the discontinuation, demand for metal-on-metal bearings was extremely low and was not expected to increase. In the United States and Europe in 2012, metal-on-metal bearings comprised less than two percent of the bearings implanted.1 This represented a 90 percent decline in industry sales since 2007.
The discontinuation became effective August 31, 2013. For more information on the discontinuation of ULTAMET Metal-on-Metal, please click here.
- Based on multiple sources including Orthopedic News Network, industry surveys and internal company estimates